NIH Unveils AI Tool ‘GeneAgent’ to Boost Reliability of Gene Set Analysis Using Expert-Validated Databases

The National Institutes of Health has introduced GeneAgent, an artificial intelligence-powered tool designed to improve the precision and reliability of gene set analysis—a process crucial to understanding diseases at a molecular level. Unlike conventional AI systems, GeneAgent employs a robust self-verification process to cross-check its genomic insights against trusted, expert-curated databases. Independent evaluation by human experts confirmed the tool’s efficacy in reducing common AI-originated errors, known as hallucinations. In initial trials, GeneAgent outperformed GPT-4 in producing trustworthy, fact-supported reports. The system’s early use in animal-model research signaled possible breakthroughs in drug target identification, underlining the promise of AI-assisted biomedical analysis while cautioning that full human-level reasoning remains elusive.

Read more